Pharmacology and Therapeutics

The risk of drug resistance during long-acting antimicrobial therapy
Anjalika Nande, Alison L. Hill

medRxiv 2021.07.10.21260044; doi: https://doi.org/10.1101/2021.07.10.21260044

Add to Selected Citations
Ethnic disparities in medication adherence? A systematic review examining the association between ethnicity and antidiabetic medication adherence
Rayah Asiri, Adam Todd, Anna Robinson, Andy Husband

medRxiv 2022.07.28.22277324; doi: https://doi.org/10.1101/2022.07.28.22277324

Add to Selected Citations
A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years
Alistair W Vickery, Sebastian Roth, Tracie Ernenwein, Jessica Kennedy, Patrizia Washer

medRxiv 2022.07.22.22277770; doi: https://doi.org/10.1101/2022.07.22.22277770

Add to Selected Citations
The Role of Home Medication Storage Location in Increasing Medication Adherence for Older Adults
Lisa Gualtieri, Eden Shaveet, Brandon Estime, Avi Patel

medRxiv 2022.07.21.22277904; doi: https://doi.org/10.1101/2022.07.21.22277904

Add to Selected Citations
Geographical disparities and differences in medical specialty prescribing of dronabinol in Medicare from 2014 to 2019
Dayna S DeSalve, Kenneth L McCall, Brian J Piper

medRxiv 2022.07.20.22277818; doi: https://doi.org/10.1101/2022.07.20.22277818

Add to Selected Citations
Real-world effectiveness of early molnupiravir and nirmatrelvir/ritonavir among hospitalized, non-oxygen-dependent COVID-19 patients on admission during Hong Kong’s Omicron BA.2 wave: an observational study
Carlos K.H. Wong, Ivan C.H. Au, Kristy T.K. Lau, Eric H.Y. Lau, Benjamin J. Cowling, Gabriel M. Leung

medRxiv 2022.05.19.22275291; doi: https://doi.org/10.1101/2022.05.19.22275291

Add to Selected Citations
Interspecies normalization of dose response relationship for adeno-associated virus-mediated hemophilia gene therapy – application to first-in-human dose prediction
Peng Zou

medRxiv 2022.07.09.22277452; doi: https://doi.org/10.1101/2022.07.09.22277452

Add to Selected Citations
Rucaparib blocks SARS-CoV-2 virus binding to cells and interleukin-6 release in a model of COVID-19
Henrietta Papp, Judit Bóvári-Biri, Krisztina Bánfai, Péter Juhász, Mohamed Mahdi, Lilian Cristina Russo, Dávid Bajusz, Adrienn Sipos, László Petri, Ágnes Kemény, Mónika Madai, Anett Kuczmog, Gyula Batta, Orsolya Mózner, Dorottya Vaskó, Edit Hirsch, Péter Bohus, Gábor Méhes, József Tőzsér, Nicola J. Curtin, Zsuzsanna Helyes, Attila Tóth, Nicolas C. Hoch, Ferenc Jakab, György M. Keserű, Judit E. Pongrácz, Péter Bai

medRxiv 2022.06.30.22277079; doi: https://doi.org/10.1101/2022.06.30.22277079

Add to Selected Citations
Suspected Adverse Drug Reactions of the Type 2 Antidiabetic Drug Class Dipeptidyl-Peptidase IV inhibitors (DPP4i): Can polypharmacology help explain?
Lauren Jones, Alan M. Jones

medRxiv 2022.06.30.22277085; doi: https://doi.org/10.1101/2022.06.30.22277085

Add to Selected Citations
Patterns of antibiotic cross-resistance by bacterial sample source: a retrospective cohort study
Stacey S. Cherny, Michal Chowers, Uri Obolski

medRxiv 2022.03.31.22273223; doi: https://doi.org/10.1101/2022.03.31.22273223

Add to Selected Citations

Pharmacology and Therapeutics

Pages